Clinical Trial Update: Neuragen for Peripheral Diabetic Neuropathy [Phase 3]

View source ↗

Summary

A Phase 3 trial of Neuragen for diabetic peripheral neuropathy and diabetic neuralgia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuralgia
• Diabetic Peripheral Neuropathy

Drugs mentioned

• Neuragen

Snippet

Sponsor: The Canadian College of Naturopathic Medicine | Conditions: Diabetic Peripheral Neuropathy, Diabetic Neuralgia | Phase 3 | Status: WITHDRAWN